India Qpcr Instruments Market Size & Outlook, 2026-2033
- Clinical Diagnostics
- In Vitro Diagnostics
- QPCR Instruments Market Outlook
- In Vitro Diagnostics
India Qpcr Instruments Market, 2021-2033 (US$M)
Global Market
Related Markets
Ask a question about the qpcr instruments market
India qpcr instruments market highlights
- The India qpcr instruments market generated a revenue of USD 37.5 million in 2025 and is expected to reach USD 67.4 million by 2033.
- The India market is expected to grow at a CAGR of 7.8% from 2026 to 2033.
- In terms of segment, quantstudio was the largest revenue generating type in 2025.
- QuantStudio is the most lucrative type segment registering the fastest growth during the forecast period.
Qpcr instruments market data book summary
| Market revenue in 2025 | USD 37.5 million |
| Market revenue in 2033 | USD 67.4 million |
| Growth rate | 7.8% (CAGR from 2026 to 2033) |
| Largest segment | Quantstudio |
| Fastest growing segment | QuantStudio |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | QuantStudio, LightCycler, Cobas 4800/5800/6800/8800, GeneXpert, Rotor-Gene Q, BioFire FilmArray System, BMS Mic System, Cobas Z480, CFX |
| Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Danaher Corp, Qiagen NV, Agilent Technologies Inc, Abbott Laboratories, BioMerieux SA, Azure Biosystems, Bio Molecular Systems |
Other key industry trends
- In terms of revenue, India accounted for 3.2% of the global qpcr instruments market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China qpcr instruments market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 113.3 million by 2033.
Healthcare reforms in India are underway, as the healthcare expenditure is expected to grow at a rate of over 15% each year. However, healthcare expenditure was as low as 1.28% of GDP in 2019. In addition, growing incidence of diseases is exerting greater demand on healthcare infrastructure.
Government initiatives, such as Ayushman Bharat and PMNRF, are anticipated to improve public access to diagnostics and treatments. This is likely to propel the growth of accredited laboratories that can meet the demand created by a growing disease burden.
In India, testing infectious diseases has led to increasing demand for qPCR instruments. Major infectious diseases, such as sexually transmitted diseases, HIV/AIDS, ventilator-acquired pneumonia, tuberculosis.
No credit card required*
Publish Date: Mar 12, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
QPCR Instruments Market Scope
QPCR Instruments Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Azure Biosystems | View profile | 51-100 | Dublin, California, United States, North America | www.azurebiosystems.com/ |
| Bio Molecular Systems | View profile | 11-50 | Upper Coomera, Queensland, Australia, Oceania | biomolecularsystems.com |
India QPCR Instruments Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to QPCR Instruments Market Outlook will help companies and investors design strategic landscapes.
Quantstudio was the largest segment with a revenue share of 30.13% in 2025.
Horizon Databook has segmented the India qpcr instruments market based on quantstudio, lightcycler, cobas 4800/5800/6800/8800, genexpert, rotor-gene q, biofire filmarray system, bms mic system, cobas z480, cfx covering the revenue growth of each sub-segment from 2021 to 2033.
Healthcare reforms in India are underway, as the healthcare expenditure is expected to grow at a rate of over 15% each year. However, healthcare expenditure was as low as 1.28% of GDP in 2019. In addition, growing incidence of diseases is exerting greater demand on healthcare infrastructure.
Government initiatives, such as Ayushman Bharat and PMNRF, are anticipated to improve public access to diagnostics and treatments. This is likely to propel the growth of accredited laboratories that can meet the demand created by a growing disease burden.
In India, testing infectious diseases has led to increasing demand for qPCR instruments. Major infectious diseases, such as sexually transmitted diseases, HIV/AIDS, ventilator-acquired pneumonia, tuberculosis.
- India Qpcr Instruments Market Type Outlook (Revenue, USD Million , 2021-2033)
- 7500
- QuantStudio
- One Step/One Step Plus
- LightCycler
- cobas 4800/5800/6800/8800
- GeneXpert
- Rotor-Gene Q
- BioFire FilmArray System
- BMS Mic System
- cobas Z480
- CFX
- Others
Reasons to subscribe to QPCR Instruments Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of QPCR Instruments Market Outlook databook
- Our clientele includes a mix of QPCR Instruments Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India QPCR Instruments Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India QPCR Instruments Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.